Arkolith/Insider Trading/ONCT/Form 4

Leavitt Chase C.

General Counsel/SecretaryOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Oct 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
0 non-derivative · 9 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2023Disposed to issuer(D)29K——0
Oct 2, 2023Grant(A)210K——210K
Oct 2, 2023Grant(A)29K——29K
Oct 2, 2023Disposed to issuer(D)65K——0
Oct 2, 2023Disposed to issuer(D)56K——0
Oct 2, 2023Grant(A)235K—$0235K
Oct 2, 2023Disposed to issuer(D)210K——0
Oct 2, 2023Grant(A)65K——65K
Oct 2, 2023Grant(A)56K——56K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML